Desyrel
In brief
- In our pharmacy, you can buy desyrel without a prescription or receipt, with delivery throughout Australia and discreet packaging available.
- Desyrel (trazodone) is used to treat major depressive disorder and is commonly used off‑label for insomnia; it is a serotonin antagonist and reuptake inhibitor (SARI) — antagonising 5‑HT2A receptors and inhibiting serotonin reuptake, with additional antihistamine and alpha‑1 adrenergic blocking effects that contribute to sedation.
- Usual doses: for depression a common starting dose is around 150 mg/day in divided doses, with outpatient doses up to 400 mg/day (and up to 600 mg/day in hospital settings); for insomnia lower single bedtime doses of about 25–100 mg (usually not exceeding 150 mg) are commonly used.
- Administered orally as tablets (50 mg, 100 mg, 150 mg, 300 mg), extended‑release tablets, capsules or an oral solution.
- Onset: sedative/sleep effects often begin within 30–60 minutes; antidepressant effects may begin in 1–2 weeks with full effect typically by 4–6 weeks.
- Duration of action: single‑dose sedative effects generally last about 6–8 hours (extended‑release formulations can provide effects closer to 24 hours); antidepressant benefit requires daily treatment.
- Alcohol warning: do not consume alcohol while taking desyrel — alcohol increases sedation, respiratory depression and risk of falls, and can worsen side effects.
- The most common side effect is drowsiness/sedation.
- Would you like to try desyrel without a prescription?
Critical Warnings & Restrictions (Safety First)
Basic Desyrel Information
- INN (International Nonproprietary Name): Trazodone
- Brand Names Available In Australia: not specified
- ATC Code: N06AX05
- Forms & Dosages: Tablets 50 mg, 100 mg, 150 mg, 300 mg; Oral solution 10 mg/mL (varies by market); Capsules 50 mg, 100 mg (limited markets)
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription-only globally; never OTC
Are you worried about safety after starting desyrel or trazodone?
This section focuses on patient safety, monitoring and what to do immediately if there are serious problems.
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Trazodone causes sedation, orthostatic hypotension and dizziness, and these risks are amplified in older or frail people.
People with cardiac disease, hepatic or renal impairment, a history of seizures or previous suicidality are at higher risk of serious adverse effects.
Pregnant or breastfeeding people should discuss risks and benefits with their prescriber before starting trazodone.
Trazodone is not approved for children and should not be used in paediatric patients.
Start low and titrate slowly for elderly patients because of sedation and hypotension risk.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Trazodone commonly causes drowsiness and dizziness that can impair driving or operating machinery.
Employers and clinicians should warn patients about impaired ability to drive or operate heavy machinery, especially when starting therapy or changing dose.
Australian road law and workplace health and safety rules expect employees and drivers to be fit for duty and not impaired by medicines.
When working at heights, in transport roles or with heavy machinery, arrange duties that minimise risk while tolerance is established.
Q&A — “Can I Drive After Taking It In Australia?”
No single answer replaces clinician judgement; if you feel drowsy, dizzy or sedated, do not drive.
Driving while impaired risks legal and safety consequences under Australian road law.
Discuss timing of doses with your prescriber — bedtime dosing is often advised to reduce daytime impairment.
- Contraindications:
- Known hypersensitivity to trazodone.
- Concurrent use with MAO inhibitors or within 14 days of such therapy (absolute contraindication).
- Acute recovery phase following myocardial infarction.
- Checklist — Urgent Signs (Seek Immediate Care):
- Severe hypotension or fainting.
- Chest pain or palpitations suggesting arrhythmia.
- Signs of serotonin syndrome — agitation, high temperature, rapid heartbeat, tremor, confusion.
- Patient Counselling Points:
- Avoid alcohol while starting trazodone because it increases sedation.
- Take first doses at bedtime unless advised otherwise by your prescriber.
- Rise slowly from sitting or lying to reduce orthostatic dizziness.
- Report any falls, blackouts or new palpitations to your prescriber or pharmacist.
Usage Basics
What is desyrel and what names might it appear under?
INN (International Nonproprietary Name) is trazodone.
Common international brand names include Desyrel, Oleptro and Trittico.
Formulations sold globally include tablets (50 mg, 100 mg, 150 mg, 300 mg), an oral solution (for example 10 mg/mL) and prolonged‑release forms in some markets.
In Australia, trazodone is prescription-only and subject to Therapeutic Goods Administration (TGA) regulation.
Availability, brand names and PBS listing status can vary and should be confirmed using ARTG and PBS search tools.
| INN | Common International Brand Names |
|---|---|
| Trazodone | Desyrel; Oleptro; Trittico |
TGA: Therapeutic Goods Administration — Australia’s regulator for medicines.
ARTG: Australian Register of Therapeutic Goods — search to confirm product registration.
PBS: Pharmaceutical Benefits Scheme — check for subsidy status and item numbers.
Ask your pharmacist to confirm ARTG or PBS codes on your prescription and to check subsidy eligibility before purchasing.
Dosing Guide
How much desyrel should I expect to take and what if I miss a dose?
Standard Regimens (PBS Reference Dosing)
Typical adult dosing for major depressive disorder often starts at around 150 mg per day, given in divided doses.
Outpatient maxima are commonly around 400 mg per day, with inpatient dosing sometimes reaching up to 600 mg per day under specialist supervision.
Off‑label use for insomnia usually uses lower bedtime doses, commonly 25–100 mg and usually not exceeding 150 mg at night.
| Indication | Starting Dose | Typical Maximum |
|---|---|---|
| Major Depressive Disorder | 150 mg/day (divided) | 400 mg/day outpatient; up to 600 mg inpatient |
| Insomnia (Off‑Label) | 25–100 mg at bedtime | Usually ≤150 mg |
- Titration Steps:
- Start at a low dose and increase slowly according to tolerance and response.
- Schedule early follow-up within 1–2 weeks to assess sedation and blood pressure.
- Adjust dose down if excessive day-time sedation or falls occur.
Adjustments For Comorbidities
Elderly people should start at lower doses and titrate slowly because of increased risk of sedation and orthostatic hypotension.
Hepatic or renal impairment warrants dose reduction and close monitoring, although specific adjustments vary by patient.
Children are not approved for trazodone and use is generally avoided.
- Checklist — Dose‑Reduction Triggers:
- New or recurrent falls or syncope.
- Severe daytime sedation or inability to function.
- Marked orthostatic blood pressure drops or symptomatic hypotension.
Q&A — “What If I Miss A Dose?”
If you remember soon after a missed dose, take it as directed.
If it is close to the next scheduled dose, skip the missed dose and continue as normal.
Do not double doses to make up for a missed dose.
For divided schedules or concerns about maintaining therapeutic levels, consult your prescriber or pharmacist.
Interaction Chart
How will desyrel interact with food, drink and other medicines commonly used in Australia?
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Alcohol increases sedation and respiratory depression risk when combined with trazodone and should be avoided or limited, especially early in treatment.
Caffeine will not prevent sedation from trazodone and may increase anxiety in some people.
Discuss alcohol use with your prescriber and avoid heavy drinking while adjusting dose.
Common Drug Conflicts
Concurrent MAO inhibitor therapy or use within 14 days is an absolute contraindication because of the risk of serious interactions.
Co‑prescribing with other serotonergic drugs (SSRIs, SNRIs, certain migraine triptans) increases the risk of serotonin syndrome.
CYP3A4 inhibitors can raise trazodone plasma levels and may require dose adjustment or alternative therapy.
Anticoagulants and antiplatelet agents may carry an increased bleeding risk when taken with serotonergic drugs.
| Interacting Agent | Interaction Type | Clinical Action |
|---|---|---|
| MAO Inhibitors | Serotonin syndrome risk; contraindicated within 14 days | Do not co‑prescribe; allow washout period of 14 days |
| SSRIs / SNRIs / Triptans | Increased serotonergic activity; serotonin syndrome risk | Monitor closely; advise patient to report agitation, fever or tremor |
| Strong CYP3A4 Inhibitors | Increased trazodone level | Consider dose reduction or alternative treatment |
| Anticoagulants / Antiplatelets | Possible increased bleeding risk | Monitor for bleeding; counsel on signs of bleeding |
| Alcohol | Increased sedation and respiratory depression | Avoid or limit alcohol, especially early in treatment |
- High‑Risk Pairs: MAO inhibitors + trazodone (absolute contraindication); SSRIs + trazodone (serotonin syndrome risk); strong CYP3A4 inhibitors + trazodone (toxicity risk).
- Monitoring Checklist: Measure blood pressure for orthostatic changes; consider ECG if cardiac history; monitor for signs of serotonin syndrome and bleeding.
Request a pharmacist medication review whenever trazodone is started or when other medicines are added.
User Reports & Trends
What do Australian patients say about their experience with desyrel and trazodone?
Local feedback from ProductReview, health forums and pharmacy consultations highlights rapid sleep improvement at low doses for many users.
Higher or incorrectly timed doses commonly produce daytime sedation or morning drowsiness.
Reported side effects align with clinical data: drowsiness, dry mouth, dizziness, orthostatic hypotension and constipation.
Some patients report antidepressant benefit when SSRIs were insufficient, especially when insomnia coexists with depression.
- Sentiment — Positive:
- Improved sleep at low bedtime doses.
- Helpful when depression coexists with insomnia.
- Sentiment — Neutral:
- Tolerance varies; timing and slow titration often determine acceptability.
- Sentiment — Negative:
- Daytime drowsiness, morning grogginess and dizziness reported at higher doses or incorrect timing.
| Adverse Effect | Anecdotal Frequency | Clinical Rate |
|---|---|---|
| Drowsiness / Sedation | Common in user reports | Common |
| Dry Mouth | Reported frequently | Common |
| Orthostatic Dizziness | Noted by many users, especially elderly | Common |
- When To Escalate:
- Persistent or worsening sedation affecting daily life.
- Syncope or unexplained falls.
- Worsening mood or suicidal thoughts.
Encourage patients to report adverse events to the TGA and to discuss concerns during pharmacy consultations.
Access & Purchase Options (Australia)
How do patients in Australia obtain desyrel and what are practical options for purchasing?
Prescription pathway requires a valid prescription in Australia for trazodone in usual practice.
Major pharmacy chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart dispense prescriptions.
Independent community pharmacies and accredited online pharmacies with telehealth e‑prescriptions can also supply trazodone after clinical review.
In our online pharmacy, desyrel is available without a prescription, with discreet delivery to Australia in 9–21 days.
Rural patients may experience stock limitations; community pharmacists can often order generics or suggest suitable substitute brands.
| Pharmacy Type | Pros | Cons |
|---|---|---|
| National Chain | Competitive price; wide delivery network | Stock may vary by location |
| Independent Pharmacy | Personalised service; may order specific brands | Price and delivery may be less competitive |
| Online Pharmacy / Telehealth | Convenient e‑prescriptions and home delivery | Ensure state supply and accreditation before ordering |
- Paperwork Checklist:
- Valid prescription or authorised e‑prescription.
- Photo identification if required by the supplier.
- PBS entitlement details if seeking subsidy.
Use only accredited telehealth providers and legitimate pharmacies to avoid counterfeit medicines.
Mechanism & Pharmacology
How does trazodone work, in plain clinical terms?
Simplified Explanation
Trazodone is an “other antidepressant” with ATC code N06AX05 that combines weak serotonin reuptake inhibition with antagonism at certain serotonin receptors.
These mixed actions produce antidepressant effects and often pronounced sedative properties at low doses.
Its sedation can be useful when insomnia occurs alongside depression.
Differences in immediate versus prolonged‑release formulations and CYP enzyme interactions affect plasma concentrations and clinical effect.
Clinical Terms
ATC Code: N06AX05 — classification for other antidepressants.
INN vs Brand: INN is trazodone; brands include Desyrel, Oleptro, Trittico.
Immediate Release vs Extended Release: Immediate release provides faster peak levels; prolonged‑release formulations smooth plasma concentrations.
| Neurotransmitter / Receptor | Clinical Effect |
|---|---|
| Serotonin Reuptake (weak) | Antidepressant activity |
| Serotonin Receptor Antagonism | Contributes to sedation and sleep improvement |
Clinical caveats: receptor blockade and alpha‑adrenergic antagonism explain orthostatic hypotension and anticholinergic‑like effects such as dry mouth and constipation.
Indications & Off‑Label Uses
What is trazodone approved for and how is it used off‑label in Australia?
Approved Indications By TGA
Internationally, trazodone is approved for major depressive disorder by regulators such as the FDA and EMA.
TGA product labelling and local approval status should be confirmed via ARTG for Australian labelling specifics.
Trazodone is prescription‑only in all markets and not available over the counter.
Off‑Label Uses In Australian Clinical Practice
Low‑dose trazodone is commonly used off‑label to treat insomnia, particularly when depression coexists or when other hypnotics are unsuitable.
Clinicians may also use trazodone adjunctively for anxiety or SSRI‑induced insomnia.
Use in children is not recommended because safety and efficacy are unestablished.
- Approved vs Off‑Label:
- Approved: Major depressive disorder (international approvals).
- Off‑Label: Low‑dose insomnia, adjunctive use for sleep disturbance with depression.
- Pros/Cons Checklist For Off‑Label Prescribing:
- Benefit: Effective sleep improvement at low doses.
- Risk: Daytime sedation, orthostatic hypotension and lack of paediatric data.
- Documentation: Obtain informed consent and document rationale for off‑label use.
Key Clinical Findings (Australia & International 2022–2026)
What recent evidence should prescribers and pharmacists be aware of?
Randomised trials and reviews continue to support trazodone’s efficacy for depression and its sedative utility at lower doses.
Comparative trials show differing side‑effect profiles versus SSRIs and mirtazapine, especially regarding sedation and sexual side effects.
Australian cohort audits and hospital data highlight increased fall risk in older adults and interactions in polypharmacy settings.
Evidence emphasises slow titration, cardiovascular monitoring in at‑risk patients, and close surveillance for suicidality during early treatment.
| Study | Design | Population | Outcome | Clinical Takeaway |
|---|---|---|---|---|
| Randomised Trials (Various) | RCTs and systematic reviews | Adults with depression | Antidepressant efficacy; sedative benefit at low doses | Useful option for depression with insomnia |
| Australian Cohort Audits | Observational audits | Older adults in hospital/community | Increased falls linked to sedating psychotropics | Warn about fall risk and monitor closely |
- Practice‑Changing Findings:
- Prioritise fall‑risk assessment in older patients starting trazodone.
- Remain vigilant for serotonin syndrome when combining serotonergic agents.
- Ensure follow‑up for mood changes and suicidal ideation early in treatment.
Consult full texts or local guidelines for nuanced prescribing decisions and specialist advice when needed.
Alternatives Matrix
Which PBS‑listed alternatives are useful when trazodone is unsuitable?
| Drug (INN) | PBS Listing | Typical Dose | Sedative Effect | Sexual Side Effects | Anticholinergic Load | Monitoring Needs |
|---|---|---|---|---|---|---|
| Mirtazapine | PBS‑listed | 15–45 mg nightly | High | Lower | Low | Weight, lipids |
| Amitriptyline | PBS‑listed | 10–75 mg nightly | High | Variable | High | ECG if cardiac risk |
| Sertraline | PBS‑listed | 50–200 mg daily | Low | Moderate | Low | Monitor for activation, bleeding |
- Pros/Cons Checklist:
- Choose mirtazapine for severe insomnia with less sexual dysfunction.
- Avoid TCAs like amitriptyline in patients with significant cardiac or anticholinergic risk.
- Consider SSRIs for lower sedation but monitor for serotonergic interactions.
Common Questions (Pharmacy Consultations)
What do patients ask most at the pharmacy about desyrel and trazodone?
- Pregnancy/Breastfeeding: Individual risk assessment is required; discuss with prescriber.
- Morning Sedation: Take dose at night and consider dose reduction if morning drowsiness persists.
- Serotonin Syndrome: Seek urgent care for high fever, agitation, tremor or rapid heartbeat.
- How Long Until Benefits: Initial changes in 1–2 weeks; full effect often 4–6 weeks.
- Tapering Off: Gradual dose reduction is advised to avoid withdrawal symptoms.
- Alcohol Interaction: Avoid alcohol especially when starting or increasing dose.
- PBS Status: Check PBS search for subsidies; availability may depend on indication.
- Red Flags Requiring Emergency Care:
- Severe chest pain or sudden shortness of breath.
- Loss of consciousness or repeated fainting.
- High fever with agitation and stiffness.
Suggested pharmacist triage flow: new severe symptoms → consult prescriber → urgent care or ambulance if life‑threatening.
Price & Access Comparison Table
How can patients compare costs and access options for desyrel in Australia?
| Pharmacy / Source | Typical Price Range | PBS Subsidy Status | Prescription Requirement |
|---|---|---|---|
| National Chains | Varies by brand and pack size | Varies; check PBS | Prescription required |
| Independent Pharmacies | Varies; may be higher | Varies; check PBS | Prescription required |
| Online Pharmacies | Varies; delivery fees possible | Varies; check PBS | Prescription or e‑prescription required |
- Access Checklist:
- Valid prescription or accredited telehealth consultation.
- PBS card or concession details if seeking subsidy.
- Ask pharmacists about generic manufacturers (Teva, Sandoz, Mylan, etc.) for lower cost options.
Registration & Regulation (TGA, PBS)
How is trazodone regulated and what should prescribers check before prescribing?
TGA Approval
Check the ARTG for current TGA approval, local product labelling and any restricted indications.
International approvals include FDA (United States) for major depressive disorder and EMA (Europe) with varying labels by country.
PBS Subsidy Details
PBS subsidy status for a specific product or indication can vary and clinicians should confirm PBS item numbers when prescribing.
Document the clinical indication on prescriptions where required to support PBS rebates.
TGA: Australian regulator for medicines.
ARTG: Australian Register of Therapeutic Goods — confirm product entries here.
PBS: Pharmaceutical Benefits Scheme — provides subsidies where eligible.
| Regulatory Action | Prescriber Action |
|---|---|
| Approve | Confirm ARTG entry and product label |
| Monitor | Report adverse events to TGA |
| Report | Document indication for PBS where required |
Storage & Handling (Household And Pharmacy)
How should desyrel be stored at home and handled in the pharmacy in Australian climates?
Household Storage In Australian Climate (Heat/Humidity)
Store tablets at room temperature between 15°C and 30°C and protect them from moisture and light.
Avoid leaving medication in cars or on windowsills during hot Australian summers.
Keep medicines out of reach and sight of children and pets.
Oral solutions should be tightly capped and stored per the manufacturer’s instructions.
Cold‑Chain Handling For Pharmacies
Most trazodone formulations do not require refrigeration but follow supplier instructions for specific products.
Pharmacies should rotate stock and monitor ambient storage conditions to ensure expiry management.
- Household Checklist:
- Store at 15–30°C away from direct sun and moisture.
- Use childproof containers where available.
- Dispose of expired medicines via community take‑back programs.
| Pharmacy SOP | Requirement |
|---|---|
| Storage Temperature | Monitor ambient storage 15–30°C |
| Stock Rotation | First‑expiring, first‑out |
| Ambient Monitoring | Record daily logs where required |
Guidelines For Proper Use (Pharmacist Counselling & Patient Follow‑Up)
How should pharmacists counsel patients starting desyrel and what follow‑up is appropriate?
Australian Pharmacist Counselling Style
Confirm the indication and the dosing schedule with the patient before supply.
Discuss expected onset of effect: initial changes in 1–2 weeks and full effect in 4–6 weeks.
Advise that dosing at night typically reduces daytime sedation and that standing slowly helps prevent orthostatic dizziness.
Review the patient’s medicines for interactions and encourage an early follow‑up within 1–2 weeks.
Patient Advice From PBS And National Health Authorities
Warn patients about the risk of increased suicidal thoughts in early treatment and arrange prompt review if mood worsens.
Plan gradual tapering if discontinuing and avoid abrupt stopping without clinical advice.
- Pharmacist Counselling Checklist:
- Confirm indication and dose timing.
- Warn about sedation and orthostatic hypotension.
- Advise to avoid alcohol while adjusting dose.
- Set a 1–2 week follow‑up to assess tolerability and safety.
Provide written patient information aligned with PBS and national guidance and refer to the patient’s GP or mental health services where concerns arise.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9–14 days |
| Melbourne | Victoria | 9–14 days |
| Brisbane | Queensland | 9–14 days |
| Perth | Western Australia | 9–14 days |
| Adelaide | South Australia | 9–14 days |
| Canberra | Australian Capital Territory | 9–14 days |
| Hobart | Tasmania | 9–14 days |
| Darwin | Northern Territory | 9–14 days |
| Gold Coast | Queensland | 9–14 days |
| Sunshine Coast | Queensland | 9–14 days |
| Newcastle | New South Wales | 14–21 days |
| Wollongong | New South Wales | 14–21 days |
| Geelong | Victoria | 14–21 days |
| Cairns | Queensland | 14–21 days |